Wednesday, July 8, 2026

biotech · Respiratory Distress Syndrome · Cardiogenic Shock · WINT

WINDTREE THERAPEUTICS INC

WINDTREE THERAPEUTICS INC clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

2600 Kelly Rd., Suite 100, Warrington, PA 18976, US HQ
1992 Founded
17 Employees
Public company Type
WINT · NYSE Ticker
Company details
Status
Public
HQ
2600 Kelly Rd., Suite 100, Warrington, PA 18976, US
Founded
1992
Employees
17
Programs
15
Drugs
9
Patents
4
Intelligence · Clinical Programs

WINDTREE THERAPEUTICS INC projects

1 ClinicalTrials.gov programs sponsored by WINDTREE THERAPEUTICS INC.

WINDTREE THERAPEUTICS INC has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. Lucinactant

    WINDTREE THERAPEUTICS INC /DE/

    Meconium Aspiration

    phase 3 small molecule terminated

    1 trial

Frequently asked questions

How many clinical projects does WINDTREE THERAPEUTICS INC have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.